摘要
许多证据表明microRNA-205(MIR-205)在正常的生理中的关键调解作用以及其在许多癌症中的异常表达。事实上,miR-205已经被证实为既是抑制肿瘤也是致癌的miRNA,通过调节不同细胞通路例如细胞存活、凋亡、血管生成和转移在肿瘤发生中扮演重要角色。作为肿瘤抑制基因, miR-205可作为细胞的增殖、迁移和侵袭的抑制剂;另一方面,作为致癌基因,miR-205促进肿瘤发生和发展;在多种类型的癌症中作用于不同靶基因实现所有这些功能。同时,miR-205也展示了其作为多种癌症治疗靶标的潜力。总的来说,miR-205在不同癌症中有重要的临床和药理相关性,并作为诊断和预后的标志物以及癌症治疗的新的分子靶标。
关键词: 许多证据表明microRNA-205(MIR-205)在正常的生理中的关键调解作用以及其在许多癌症中的异常表达。事实上,miR-205已经被证实为既是抑制肿瘤也是致癌的miRNA,通过调节不同细胞通路例如细胞存活、凋亡、血管生成和转移在肿瘤发生中扮演重要角色。作为肿瘤抑制基因, miR-205可作为细胞的增殖、迁移和侵袭的抑制剂;另一方面,作为致癌基因,miR-205促进肿瘤发生和发展;在多种类型的癌症中作用于不同靶基因实现所有这些功能。同时,miR-205也展示了其作为多种癌症治疗靶标的潜力。总的来说,miR-205在不同癌症中有重要的临床和药理相关性,并作为诊断和预后的标志物以及癌症治疗的新的分子靶标。 癌,癌症,miRNA-205
图形摘要
Current Cancer Drug Targets
Title:The Important Roles of miR-205 in Normal Physiology, Cancers and as a Potential Therapeutic Target
Volume: 14 Issue: 7
Author(s): Haleh Vosgha, Ali Salajegheh, Robert Anthony Smith and Alfred King-Yin Lam
Affiliation:
关键词: 许多证据表明microRNA-205(MIR-205)在正常的生理中的关键调解作用以及其在许多癌症中的异常表达。事实上,miR-205已经被证实为既是抑制肿瘤也是致癌的miRNA,通过调节不同细胞通路例如细胞存活、凋亡、血管生成和转移在肿瘤发生中扮演重要角色。作为肿瘤抑制基因, miR-205可作为细胞的增殖、迁移和侵袭的抑制剂;另一方面,作为致癌基因,miR-205促进肿瘤发生和发展;在多种类型的癌症中作用于不同靶基因实现所有这些功能。同时,miR-205也展示了其作为多种癌症治疗靶标的潜力。总的来说,miR-205在不同癌症中有重要的临床和药理相关性,并作为诊断和预后的标志物以及癌症治疗的新的分子靶标。 癌,癌症,miRNA-205
摘要: Evidences have demonstrated key mediatory roles of microRNA-205 (miR-205) in normal physiology and its aberrant expression in many cancers. Indeed, miR-205 has been identified as both a tumour suppressive and oncogenic miRNA playing crucial roles in tumourigenesis through regulating different cellular pathways such as cell survival, apoptosis, angiogenesis and metastasis. As a tumour suppressor, miR-205 acts as an inhibitor of cell proliferation, migration and invasion. On the other hand, as an oncogene, miR-205 promotes tumour initiation and development. All these functions act through different target genes in various types of cancers. Also, miR-205 displays potential as a therapeutic target for different cancers. To conclude, miR-205 has important clinical and pathological correlations in different cancers and may act as a diagnostic and prognostic marker as well as new molecular target for cancer therapy.
Export Options
About this article
Cite this article as:
Vosgha Haleh, Salajegheh Ali, Smith Anthony Robert and Lam King-Yin Alfred, The Important Roles of miR-205 in Normal Physiology, Cancers and as a Potential Therapeutic Target, Current Cancer Drug Targets 2014; 14 (7) . https://dx.doi.org/10.2174/156800961407140926105634
DOI https://dx.doi.org/10.2174/156800961407140926105634 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Disorder in Milk Proteins: α-Lactalbumin. Part B. A Multifunctional Whey Protein Acting as an Oligomeric Molten Globular “Oil Container” in the Anti-Tumorigenic Drugs, Liprotides
Current Protein & Peptide Science Therapeutic Agents Based on DNA Sequence Specific Binding
Current Topics in Medicinal Chemistry Phyto-Phospholipid Complexation as a Novel Drug Delivery System for Management of Cancer with Better Bioavailability: Current Perspectives and Future Prospects
Anti-Cancer Agents in Medicinal Chemistry Interrelationships of Circulating Tumor Cells with Metastasis and Thrombosis: Role of MicroRNAs
Current Pharmaceutical Design P2X Receptors, Sensory Neurons and Pain
Current Medicinal Chemistry Protein Kinases as Drug Targets in Human and Animal Diseases
Current Enzyme Inhibition Polymer Membrane and Cell Models for Drug Discovery
Combinatorial Chemistry & High Throughput Screening Should the Status of the Pathway Mediated by BRCA1 and BRCA2 be Evaluated Before Selecting Cancer Chemotherapy Drugs?
Current Pharmacogenomics Patent Selections:
Recent Patents on Biomarkers The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
Current Medicinal Chemistry - Anti-Cancer Agents The Therapeutic Value of Natural Agents to Treat miRNA Targeted Breast Cancer in African-American and Caucasian-American Women
Current Drug Targets Heparanase as a Target in Cancer Therapy
Current Cancer Drug Targets Vascular Endothelial Growth Factor (VEGF) as a Target of Bevacizumab in Cancer: From the Biology to the Clinic
Current Medicinal Chemistry Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions
Current Signal Transduction Therapy Structure-Activity Evaluation of N-benzyl-5-substituted Indole-3-imine Derivatives and their Amine Congeners as Bovine Testicular Hyaluronidase (BTH) Inhibitor
Letters in Drug Design & Discovery Pharmacogenetics of Childhood Acute Lymphoblastic Leukemia
Current Pharmacogenomics Antileukotriene Drugs: Clinical Application, Effectiveness and Safety
Current Medicinal Chemistry LPTS: A Novel Tumor Suppressor Gene and a Promising Drug Target for Cancer Intervention
Recent Patents on Anti-Cancer Drug Discovery Therapeutic Targeting of TRP Channels - The TR(i)P to Pain Relief
Current Topics in Medicinal Chemistry Chalcones in Cancer: Understanding their Role in Terms of QSAR
Current Medicinal Chemistry